Assignee
ELEUSIS THERAPEUTICS US INC
US·3 granted patents·6 pending applications·36 citations·filing 2021–2025
Top patents by PatentIndex Score
9 records- 0191US11312684B1Pharmaceutically acceptable salts of psilocin and uses thereofELEUSIS THERAPEUTICS US INC·Filed 2021·Granted Apr 26, 2022·31 cites·17 claims
- 0290US11680043B2Pharmaceutically acceptable salts of psilocin and uses thereofELEUSIS THERAPEUTICS US INC·Filed 2022·Granted Jun 20, 2023·5 cites·16 claims
- 0383US2026062383A1Pharmaceutically acceptable salts of psilocin and uses thereofELEUSIS THERAPEUTICS US INC·Filed 2025·Application pending·0 cites
- 0481US12545642B2Pharmaceutically acceptable salts of psilocin and uses thereofELEUSIS THERAPEUTICS US INC·Filed 2023·Granted Feb 10, 2026·0 cites·13 claims
- 0565US2022117956A1Lsd for the treatment of alzheimer's diseaseELEUSIS THERAPEUTICS US INC·Filed 2021·Application pending·0 cites
- 0659US2025073207A1Psilocin benzoate formulation for intravenous infusionELEUSIS THERAPEUTICS US INC·Filed 2023·Application pending·0 cites
- 0751US2024124398A1Pharmaceutically acceptable salts of psilocin and uses thereofELEUSIS THERAPEUTICS US INC·Filed 2022·Application pending·0 cites
- 0847US2023277568A1Method of treatment for psilocybin or psilocin infusionELEUSIS THERAPEUTICS US INC·Filed 2021·Application pending·0 cites
- 0946US2021322384A1Method of Treatment for Ketamine InfusionELEUSIS THERAPEUTICS US INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →